Core Viewpoint - Far East Horizon (03360) has adopted a prudent operational strategy since 2025, leading to a year-on-year increase in profit attributable to ordinary shareholders for the first three quarters ending September 30, 2025 [1] Financial Business - The financial business has shown steady growth, with revenue increasing year-on-year, leveraging the company's deep industry expertise [1] - The total amount of interest-earning assets at the end of the review period remained stable compared to the end of 2024, with improvements in both interest margins year-on-year and quarter-on-quarter [1] - Funding costs have decreased further, and asset quality remains solid, with non-performing asset balances largely stable and a prudent provision coverage maintained [1] - The inclusive finance business model has matured, progressing steadily under controllable risk conditions, with a cautious write-off strategy [1] - The scale of interest-earning assets in the inclusive finance business has grown by over 60% year-on-year, with revenue doubling year-on-year for the first three quarters ending September 30, 2025 [1] - The fair value of investment-related businesses has continued to recover positively [1] Hongxin Health - During the review period, Hongxin Health has adhered to its established strategic direction, maintaining overall stable operations, although revenue has decreased year-on-year while remaining profitable [1]

Group 1: Financial Performance - Far East Horizon (03360) reported a year-on-year increase in profit attributable to ordinary shareholders for the first three quarters ending September 30, 2025 [1] - Financial business revenue showed steady growth, with interest-earning assets remaining stable compared to the end of 2024, and both interest margins and funding costs improved [1] - The asset quality remained solid, with non-performing asset balances stable and prudent provision coverage maintained [1] Group 2: Business Development - The inclusive finance business model has matured, with a focus on steady advancement under controllable risk conditions, and a cautious write-off strategy [1] - The inclusive finance business's interest-earning asset scale grew by over 60% year-on-year, with revenue doubling for the first three quarters ending September 30, 2025 [1] - Investment-related business fair value continued to recover positively [1] Group 3: Health Sector Performance - Hongxin Health maintained its strategic direction with overall stable operations, although revenue experienced a year-on-year decline while remaining profitable [2]

Group 1 - The core viewpoint of the articles highlights that Far East Horizon (03360.HK) has maintained a prudent operational strategy since 2025, resulting in a year-on-year increase in profit attributable to ordinary shareholders for the first three quarters ending September 30, 2025 [1] - The financial business has shown steady growth, with income increasing year-on-year, and the total interest-earning assets remaining stable compared to the end of 2024. The interest margin has improved both year-on-year and quarter-on-quarter, while funding costs have decreased [1] - The asset quality remains solid, with non-performing asset balances stable and a prudent provision coverage maintained. The inclusive finance business model has matured, with a year-on-year growth of over 60% in interest-earning assets and a doubling of income for the first three quarters ending September 30, 2025 [1] Group 2 - The company continues to adhere to a prudent risk management strategy, with effective foreign exchange rate hedging measures and consistently strong liquidity [1] - Looking ahead, the company will persist in its "finance + industry" development strategy, aiming to safely advance its business and enhance shareholder returns while continuously creating value for shareholders [2]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性 或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或因依 賴該等內容而引致的任何損失承擔任何責任。 （於香港註冊成立的有限公司） （股份代號：3360） 未經審核二零二五年第三季度營運概要 截至二零二五年九月三十日止 本公告載列遠東宏信有限公司(Far East Horizon Limited)（「本公司」）及其附屬公 司（「本集團」）截至二零二五年九月三十日止第三季度（「本回顧期」）未經審核之 營運概要。 本公告為根據香港聯合交易所有限公司（「聯交所」）證券上市規則第13.09(2)(a)條 及香港法例第571章證券及期貨條例XIVA部之要求而作出。 二零二五年以來，本集團秉承穩健審慎的經營策略，平穩推進各項業務，截至二 零二五年九月三十日止前三季度的歸屬普通股股東應佔溢利同比提升。 金融業務：持續發揮深耕產業的優勢，金融業務收入同比穩中有增。本回顧期末 的生息資產總額較二零二四年末持平微增，息差同比、環比均有提升，資金成本 進一步下降。資產質量依舊穩固，不良資產餘額基本保持穩定，撥備覆蓋維持審 慎 ...

Core Insights - Tianeng Holding Group's Chairman Zhang Tianren led a management team visit to Far East Horizon on October 10, where they engaged in in-depth discussions on green finance, global layout, and industrial innovation, culminating in the signing of a strategic cooperation framework agreement [1] Group 1 - The visit aimed to enhance collaboration in the field of green finance [1] - Discussions included strategies for global expansion and innovation within the industry [1] - A strategic cooperation framework agreement was signed to formalize the partnership [1]

Core Viewpoint - The Hong Kong Dividend Low Volatility ETF (520890) has experienced a significant decrease in both share count and total assets in 2024, indicating potential challenges in attracting investment [1][2]. Group 1: Fund Overview - The Hong Kong Dividend Low Volatility ETF (520890) was established on September 4, 2024, with an annual management fee of 0.50% and a custody fee of 0.10% [1]. - As of October 10, 2024, the fund had a total of 70.08 million shares and a total size of 98.15 million yuan, down from 123 million shares and 146 million yuan at the end of 2024, representing a 43.09% decrease in shares and a 32.92% decrease in size year-to-date [1]. Group 2: Liquidity and Trading Activity - Over the last 20 trading days, the ETF has accumulated a total trading amount of 688 million yuan, with an average daily trading amount of 34.41 million yuan [1]. - Year-to-date, the ETF has seen a total trading amount of 2.643 billion yuan over 186 trading days, averaging 14.21 million yuan per day [1]. Group 3: Fund Performance and Holdings - The current fund manager, Li Qian, has managed the ETF since its inception, achieving a return of 40.20% during her tenure [2]. - The ETF's top holdings include Shougang Resources (3.83%), Far East Horizon (3.69%), Chongqing Rural Commercial Bank (3.27%), and others, with the total holdings reflecting a diversified portfolio [2].

Investment Rating - The report maintains a positive outlook on the non-bank financial sector, indicating an "Overweight" rating for the industry, suggesting it will outperform the overall market [4][55]. Core Insights - The report highlights strong growth in the brokerage sector, with a significant increase in new A-share accounts and trading volumes, indicating a robust market environment. The net profit for the brokerage sector is expected to show high year-on-year growth for the first nine months of 2025 [4]. - The insurance sector is undergoing regulatory changes aimed at improving profitability, particularly in non-auto insurance, which is expected to benefit leading companies in the industry [4]. - The report identifies three main investment themes in the brokerage sector: 1) Stronger institutions benefiting from improved competition, 2) Brokerages with high earnings elasticity, and 3) Companies with strong international business capabilities [4]. Market Review - The Shanghai Composite Index rose by 1.47% during the period from September 29 to October 10, 2025, while the non-bank index increased by 3.18%. The brokerage sector saw a rise of 4.42%, while the insurance sector increased by 0.89% [7]. - The average daily trading volume for the Shanghai and Shenzhen stock exchanges reached 26,034.09 billion yuan, reflecting a year-on-year increase of 56.08% [15][31]. Non-Bank Industry Data - As of October 10, 2025, the financing balance in the margin trading market was 24,455.47 billion yuan, showing a year-on-year increase of 31.2% [15]. - The report notes that the average daily trading volume for the first nine months of 2025 was 26,034.09 billion yuan, indicating a vibrant trading environment [31]. Regulatory Developments - The Financial Regulatory Bureau has implemented a new framework for non-auto insurance, focusing on improving underwriting profitability and establishing stricter fee management and compliance measures [4][17]. - The report mentions the central bank's liquidity measures, including significant net injections through various monetary policy tools, which aim to maintain market liquidity [16][19].

Investment Rating - The report maintains a "Positive" outlook on the non-bank financial sector [1] Core Views - The report highlights a continuation of strong growth in the brokerage sector, with a significant increase in net profits expected for the first nine months of 2025. Key metrics include a 61% year-on-year increase in new A-share accounts and a 203% increase in average daily stock trading volume in September 2025 [2][5] - The brokerage sector is currently undervalued, with a price-to-book (PB) ratio of 1.48, placing it in the 47.8th percentile over the past decade [2] - The report notes a favorable market environment supporting continued high growth in brokerage performance, with specific recommendations for leading firms and those with strong international business capabilities [2][7] Summary by Sections Market Review - The Shanghai Composite Index rose by 1.47% during the period from September 29 to October 10, 2025, while the non-bank index increased by 3.18%. The brokerage, insurance, and diversified financial sectors reported gains of 4.42%, 0.89%, and 0.52%, respectively [5][6] Non-Bank Sector Insights - The report indicates that the insurance sector is benefiting from the implementation of a "de-involution" policy framework for non-auto insurance, which is expected to improve underwriting profitability for leading firms [2][16] - Specific investment recommendations include firms that are expected to benefit from improved competitive dynamics and those with strong earnings elasticity [2][7] Key Data Tracking - As of October 10, 2025, the average daily trading volume in the stock market was 26,034.09 billion yuan, reflecting an 18.99% increase from the previous period [14][32] - The report also tracks significant metrics such as the balance of margin financing and securities lending, which stood at 24,455.47 billion yuan as of October 9, 2025, marking a 31.2% increase from the end of 2024 [14][39]

Core Insights - The article presents a ranking of 33 Hong Kong-listed medical service companies based on their stock price performance as of September 30, 2025, highlighting significant price increases and declines among these companies [1][2]. Group 1: Top Performers - The top performer is Brainstorm Cell Therapeutics (脑动极光-B) with a stock price of HKD 8.58, reflecting a remarkable increase of 166.46% [1]. - MediWound (麦迪卫康) ranks second with a stock price of HKD 1.23, showing a growth of 136.54% [1]. - Yonghe Medical (雍禾医疗) comes in third with a stock price of HKD 2.05, marking a rise of 127.78% [1]. Group 2: Notable Declines - The company with the largest decline is Yimeng Group (云康集团), with a stock price of HKD 1.28, experiencing a drop of 86.15% [1]. - Meizhong Jiahe (美中嘉和) follows with a stock price of HKD 3.20, down by 70.91% [1]. - Another significant decline is seen in Yimeng Sunshine (一昧阳光), which has a stock price of HKD 17.00, down by 76.06% [1]. Group 3: Market Capitalization - Fosun Pharma (复星医药) has the highest market capitalization at HKD 680.48 billion, with a stock price of HKD 25.78 [2]. - Far East Horizon (远东宏信) ranks second with a market cap of HKD 328.32 billion and a stock price of HKD 6.87 [2]. - Global Medical (环球医疗) holds a market cap of HKD 114.82 billion, with a stock price of HKD 6.07 [2].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 | 截至月份: | 2025年9月30日 | 狀態: 新提交 | | --- | --- | --- | | 致：香港交易及結算所有限公司 | | | | 公司名稱: | 遠東宏信有限公司 | | | 呈交日期: | 2025年10月8日 | | | I. 法定/註冊股本變動 不適用 | | | FF301 第 1 頁 共 11 頁 v 1.1.1 FF301 II. 已發行股份及/或庫存股份變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 03360 | 說明 | | | | | | | | | 已發行股份（不包括庫存股份）數目 | | 庫存股份數目 | | 已發行股份總數 | | | 上月底結存 | | | 4,779,052,421 | | 0 | | 4,779,052,421 | | 增加 / 減少 (-) | | | 1,45 ...